During the past decade, Guangdong Provincial People's Hospital, Guangzhou conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guangdong Provincial People's Hospital, Guangzhou" #1 sponsor was "The George Institute" with 2 trials, followed by "BeiGene" with 1 trials sponsored, "Children's Hospital of Fudan University" with 1 trials sponsored, "Guangdong Association of Clinical Trials" with 1 trials sponsored and "Pfizer Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guangdong Provincial People's Hospital, Guangzhou" #1 collaborator was "Children's Hospital of Chongqing Medical University" with 1 trials as a collaborator, "Chinese PLA General Hospital" with 1 trials as a collaborator, "Guangdong Provincial People's Hospital" with 1 trials as a collaborator, "Peking University First Hospital" with 1 trials as a collaborator and "Peking University Institute of Nephrology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Guangdong Provincial People's Hospital, Guangzhou" are "ARDS" (1 trials), "ESRD" (1 trials), "Glomerulonephritis" (1 trials), "IgA Glomerulonephritis" (1 trials) and "IgA Nephropathy" (1 trials). Many other conditions were trialed in "Guangdong Provincial People's Hospital, Guangzhou" in a lesser frequency.

Most popular intervention types in "Guangdong Provincial People's Hospital, Guangzhou" are "Drug" (2 trials), "Genetic" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adjuvant treatment for MRD positivity" (1 trials), "ECMO" (1 trials), "Placebo" (1 trials), "Zanubrutinib" (1 trials) and "as per Physician's prescription" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guangdong Provincial People's Hospital, Guangzhou" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Guangdong Provincial People's Hospital, Guangzhou". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Guangdong Provincial People's Hospital, Guangzhou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guangdong Provincial People's Hospital, Guangzhou, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Guangdong Provincial People's Hospital, Guangzhou has several departments that took part in Clinical trials: "Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences" - 2 trials